There is increased risk for stroke among women experiencing homelessness and unstable housing who have cocaine and alcohol co-use.

Di-2-ethylhexylphthalate contributes to 13.497% of all cardiovascular deaths among individuals aged 55 to 64 years with considerable geographic disparities.

Urinary incontinence is not associated with moderate-to-vigorous physical activity classification but is associated with CVD risk factors and comorbidity.

Decreases in global cognition and executive function, as well as long-term persistent declines in those cognitive domains, are associated with incident HF.

Individualized approaches may enhance the safety and efficacy of music for pain management in health care settings.

A no-touch vein harvesting technique reduces vein graft occlusion and improves patient outcomes at 3-year follow-up among patients undergoing CABG surgery.

In racially and socioeconomically marginalized pediatric patients there are significant inequities in the incidence of HER behavioral flags.

For patients with metabolic dysfunction-associated steatohepatitis and fibrosis, semaglutide is associated with improved liver histologic outcomes.

Despite widespread vaccine availability and improved treatment strategies, certain patients with SARDs remain highly vulnerable to severe COVID-19 outcomes.

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.

The MACE risk associated with initiating ustekinumab is comparable to that of adalimumab, etanercept, and secukinumab in patients with PsO or PsA.